Back to Authors

Shapiro, Andrea B

Mayo Clinic

From the Division of Rheumatology, Mayo Clinic, Rochester, MN (S.R.Y.); the Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (D.L.B.); the Division of Rheumatology, University of Nebraska Medical Center, Omaha (T.R.M.

Citations 1

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

New England Journal of Medicine | January 26, 2022 | Volume: 386 | Issue: 4 | Pages: 316-326

10.1056/nejmoa2109927 | PMID 35081280